Evofem Biosciences (EVFM) Short Interest Ratio & Short Volume

Short interest is the volume of Evofem Biosciences shares that have been sold short but have not yet been closed out or covered. As of July 15th, traders have sold 123,100 shares of EVFM short. Learn More on Evofem Biosciences' current short interest.

Evofem Biosciences saw a increase in short interest in July. As of July 15th, there was short interest totaling 123,100 shares, an increase of 330.4% from the previous total of 28,600 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Evofem Biosciences: Matinas Biopharma Holdings, Inc. (1.82%), Alaunos Therapeutics, Inc. (3.78%), Qualigen Therapeutics, Inc. (1.64%), Dermata Therapeutics, Inc. (2.01%), Revelation Biosciences, Inc. (13.70%), Clearmind Medicine Inc. (17.95%), Soligenix Inc. (8.91%), Avalon GloboCare Corp. (36.90%), Virax Biolabs Group Limited (0.57%), CNS Pharmaceuticals, Inc. (6.93%),

As of the most recent reporting period, the following stocks had the largest short interest positions: Coinbase Global, Inc. ($5.11 billion), Charter Communications, Inc. ($4.76 billion), Reddit Inc. ($2.84 billion), SoFi Technologies, Inc. ($2.79 billion), Seagate Technology Holdings PLC ($2.79 billion), Live Nation Entertainment, Inc. ($2.67 billion), Rocket Lab Corporation ($2.49 billion), AST SpaceMobile, Inc. ($2.12 billion), Moderna, Inc. ($2.09 billion), and Omnicom Group Inc. ($2.04 billion). View all of the most shorted stocks.

Short selling EVFM is an investing strategy that aims to generate trading profit from Evofem Biosciences as its price is falling. EVFM shares are trading down $0.00 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Evofem Biosciences occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of EVFM, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including EVFM, twice per month. The most recent reporting period available is July, 15 2025.